About Softdeal Pharmaceutical Private Limited
Data last updated:
Softdeal Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Sun Pharmaceutical Industries Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH2006PTC159237. Its GSTIN is 27AAJCS7828N2ZH (Maharashtra). The company holds 10 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Softdeal Trading Company Private Limited. It is led by directors including Rakeshchandra Jagdishprasad Sinha and Prince Kalarickal Elias.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Acme Plaza Andheri – Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹234.63 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹39.49 Cr (net margin 16.8%) and EBITDA of ₹54.04 Cr (EBITDA margin 23%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 533% over five years.
The company has about 78 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 2 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in April 2012. The company has 9 MSME Form 1 returns on record between 2021 and 2024, listing 150 overdue payments to 17 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunpharma.com.
Company details
Contact details
Softdeal Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its website is sunpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressAcme Plaza Andheri – Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Softdeal Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Softdeal Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Softdeal Pharmaceutical Private Limited, buy the company report.
Financials of Softdeal Pharmaceutical Private Limited
FY 2025 filings availableSoftdeal Pharmaceutical Private Limited reported revenue of ₹234.63 Cr (up 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 533% over five years, including 47% growth in the latest year. EBITDA rose 455% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23% | ||||
| Net Profit Margin | 16.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Softdeal Pharmaceutical Private Limited, buy the company report.
Board of directors of Softdeal Pharmaceutical Private Limited
Softdeal Pharmaceutical has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakeshchandra Jagdishprasad Sinha | Director | 19 Apr 2019 | 7 Years 6 Months | Current |
| Prince Kalarickal Elias | Director | 29 Jan 2024 | 2 Years 9 Months | Current |
| Kedar Nath Senapati | Director | 21 Feb 2022 | 4 Years 8 Months | Current |
Auditor
Softdeal Pharmaceutical Private Limited is audited by S R B C & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Softdeal Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Softdeal Pharmaceutical Private Limited, buy the company report.
Deals & funding
Softdeal Pharmaceutical Private Limited has 2 deals on record (2 secondary share transfers); the latest was in April 2012.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2012 | Secondary share transfer | Undisclosed | Buyer: Sun Pharmaceutical Industries Limited & Sudhir Valia, Sun Pharmaceutical Industries Limited Seller: Sejraj Financial Services Limited , Khyati Financial Services Pvt Ltd , 2 individuals |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: Sejraj Financial Services Limited , Karad Chemicals and Allied Products Private Limited , 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Softdeal Pharmaceutical Private Limited has 4 court cases on record: 2 filed by Softdeal Pharmaceutical, 2 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, Assam | Court case (Review.Pet.) | Filed by the company against M/S Vaishno Devi Traders Pvt. Ltd. and Anr. and 1 other | Disposed |
| District court, Kamrup, Assam | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| District court, Kamrup, Assam | Civil suit | Filed by the company against an individual | Pending |
| District court, Kamrup, Assam | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Softdeal Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Softdeal Pharmaceutical Private Limited has 9 MSME Form 1 returns on record between 2021 and 2024, listing 150 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Shree Packers (MP) Private Limited | |||
| Shree Salasar Print and Pack | |||
| Greenways Pvt Ltd | |||
| an individual supplier | |||
| Vishruta Packaging Private Limited |
To see the full MSME payment records of Softdeal Pharmaceutical Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Softdeal Pharmaceutical Private Limited has a workforce of 78 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Softdeal Pharmaceutical has 10 GST registrations: 10 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCS7828N2ZH | Maharashtra | Active | 01 Jun 2021 |
| 27AAJCS7828N1ZI | Maharashtra | Active | 10 Jun 2021 |
| 19AAJCS7828N1ZF | West Bengal | Active | 05 Apr 2021 |
| 23AAJCS7828N1ZQ | Madhya Pradesh | Active | 08 Apr 2021 |
To see the full GST registrations and return filing status of Softdeal Pharmaceutical Private Limited, buy the company report.
Recent activity
Softdeal Pharmaceutical Private Limited has 14 board changes on record since 2011: 3 appointments and 11 cessations. The latest: Prince Kalarickal Elias ceased to be Additional Director on 29 Sep 2024.
5 earlier events are in the company report.
Frequently asked questions
Softdeal Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2006 (20+ years old) and is registered under CIN U51900MH2006PTC159237.
Softdeal Pharmaceutical has 3 current directors:
- Rakeshchandra Jagdishprasad Sinha - Director
- Prince Kalarickal Elias - Director
- Kedar Nath Senapati - Director
The latest financial statements of Softdeal Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Softdeal Pharmaceutical is 27AAJCS7828N2ZH, registered in Maharashtra. The company has 10 GST registrations in all, of which 10 are active. Other active GSTINs include 27AAJCS7828N1ZI (Maharashtra), 19AAJCS7828N1ZF (West Bengal), 23AAJCS7828N1ZQ (Madhya Pradesh).
The CIN (Corporate Identification Number) of Softdeal Pharmaceutical is U51900MH2006PTC159237. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Softdeal Pharmaceutical has 4 court cases on record: 2 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Softdeal Pharmaceutical was incorporated on 25 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Softdeal Pharmaceutical has 2 deals on record (2 secondary share transfers); the latest was in April 2012.
Prince Kalarickal Elias ceased to be Additional Director on 29 Sep 2024. Prince Kalarickal Elias was appointed as Director on 29 Jan 2024. Kedar Nath Senapati ceased to be Additional Director on 30 Sep 2022. Softdeal Pharmaceutical has 14 board changes on record in total.
Softdeal Pharmaceutical has 9 MSME Form 1 returns on record between 2021 and 2024, listing 150 overdue payments to 17 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Softdeal Pharmaceutical can be reached through the website sunpharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
